This is a Validated Antibody Database (VAD) review about chimpanzee CD33, based on 21 published articles (read how Labome selects the articles), using CD33 antibody in all methods. It is aimed to help Labome visitors find the most suited CD33 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s2e
BioLegend CD33 antibody (Biolegend, 303402) was used in flow cytometry on human samples (fig s2e). Cell (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD33 antibody (BioLegend, 303419) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD33 antibody (BioLegend, 303416) was used in flow cytometry on human samples (fig s6a). Haematologica (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:200; loading ...; fig 3c
BioLegend CD33 antibody (Biolegend, 303407) was used in flow cytometry on human samples at 1:200 (fig 3c). elife (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD33 antibody (Biolegend, 303404) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:400; loading ...; fig s10b
BioLegend CD33 antibody (Biolegend, 303415) was used in flow cytometry on human samples at 1:400 (fig s10b). Science (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD33 antibody (BioLegend, 303423) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 3c
  • immunohistochemistry; human; fig 2a
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 3c) and in immunohistochemistry on human samples (fig 2a). Oncoimmunology (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 4a
In order to assess the effects of sialic acid blockade on dendritic cells, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 4a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD33 antibody (BioLegend, 303408) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi
mouse monoclonal (WM53)
  • immunohistochemistry; human; 1:300; loading ...; fig 7b
BioLegend CD33 antibody (BioLegend, 303414) was used in immunohistochemistry on human samples at 1:300 (fig 7b). J Clin Invest (2016) ncbi
mouse monoclonal (WM53)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend CD33 antibody (BioLegend, WM53) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend CD33 antibody (BioLegend, 303414) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 3
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (WM53)
  • other; human; fig 2
  • flow cytometry; human; fig 2
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend CD33 antibody (Biolegend, WM53) was used in other on human samples (fig 2) and in flow cytometry on human samples (fig 2). Analyst (2016) ncbi
mouse monoclonal (WM53)
  • blocking or activating experiments; human; loading ...; fig 2c
In order to investigate cross-talk between Alzheimer loci, BioLegend CD33 antibody (BioLegend, WM53) was used in blocking or activating experiments on human samples (fig 2c). Nat Neurosci (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 1
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend CD33 antibody (BioLegend, WM-53) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BioLegend CD33 antibody (BioLegend, WM-53) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
Articles Reviewed
  1. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  2. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  3. Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed publisher
  4. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  5. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  6. Muhar M, Ebert A, Neumann T, Umkehrer C, Jude J, Wieshofer C, et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science. 2018;360:800-805 pubmed publisher
  7. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed publisher
  8. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  9. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  10. Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed publisher
  11. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  12. Ding L, Hayes M, Photenhauer A, Eaton K, Li Q, Ocadiz Ruiz R, et al. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia. J Clin Invest. 2016;126:2867-80 pubmed publisher
  13. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  14. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  15. Valletta S, Dolatshad H, Bartenstein M, Yip B, Bello E, Gordon S, et al. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts. Oncotarget. 2015;6:44061-71 pubmed publisher
  16. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  17. Chan G, White C, Winn P, Cimpean M, Replogle J, Glick L, et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015;18:1556-8 pubmed publisher
  18. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  19. Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology. 2014;143:588-600 pubmed publisher
  20. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  21. Martin R, Saleem S, Folgosa L, Zellner H, Damle S, Nguyen G, et al. Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. J Leukoc Biol. 2014;96:151-9 pubmed publisher